Position in TMO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,059,223
+$3,701,126 QoQ
Shares Held
10,091
+265.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#844
of 2,606 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AlphaCore Capital LLC holds $13,485,326 across 13 Diagnostics & Research names. TMO ranks #1 (37.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
10,091 | $5,059,223 | |
| 2 | DGX |
Quest Diagnostics Inc
|
9,371 | $1,986,183 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,066 | $1,087,625 | |
| 4 | DHR |
Danaher Corp /De/
|
5,557 | $1,058,497 | |
| 5 | ILMN |
Illumina, Inc.
|
4,750 | $835,192 | |
| 6 | A |
Agilent Technologies, Inc.
|
5,360 | $711,968 | |
| 7 | LH |
Labcorp Holdings Inc.
|
2,435 | $681,800 | |
| 8 | NTRA |
Natera, Inc.
|
2,139 | $580,631 |
All Filings in TMO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,059,223 | 10,091 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,358,097 | 2,763 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,689,096 | 2,915 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,356,600 | 2,797 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,676,577 | 4,135 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,769,641 | 5,566 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $845,893 | 1,626 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $216,499 | 350 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||